about
Oral Hypoglycemic Agents in pregnancy: An UpdateExpression and functional activity of PPARgamma in pancreatic beta cells.Pharmacological treatment of type 2 diabetes.Recent advances in the treatment of polycystic ovary syndrome.Do preclinical testing strategies help predict human hepatotoxic potentials?Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectivesRitonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic ratAdiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones.Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial.Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
P2860
Q26851879-DF1269A8-CF50-43A8-85FE-51284EF5FCDBQ35047497-2BB0B41C-567B-41DE-A86F-AF297A010E28Q35821479-D2C75EB2-C37B-49EC-BB15-FA1700185E09Q35906966-30AE3009-ABC5-4BEA-A950-48A4D280F512Q36086429-0FB7A8D0-2172-411D-8896-0A813420BF9AQ36812788-B4E03F3B-B7FB-49B6-9756-06D227858287Q37215121-21B14540-F57F-4182-8C67-5B964995C81EQ37591975-54216028-91A8-4EDF-99F1-EDB51DF65A52Q38320716-FB7DAD49-D1AE-4396-BB72-741763AAECC0Q38628118-E7267C4A-4306-43B5-B63C-3824761D89F1Q46433354-D956036E-3C8C-4620-8CA4-282DEBE8B351Q46495618-C11ABF54-27D5-4CF3-94E2-5DC1336FC226Q46530085-ED663C24-A829-4474-9581-FC97E481AC48Q46611073-A78C03C9-C251-4AD5-B159-E580A3269B62Q51480621-62AF077B-26C0-44FF-8626-E759639FF6FE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Thiazolidinediones -- some recent developments.
@ast
Thiazolidinediones -- some recent developments.
@en
type
label
Thiazolidinediones -- some recent developments.
@ast
Thiazolidinediones -- some recent developments.
@en
prefLabel
Thiazolidinediones -- some recent developments.
@ast
Thiazolidinediones -- some recent developments.
@en
P2860
P1476
Thiazolidinediones -- some recent developments.
@en
P2860
P304
P356
10.1517/13543784.12.7.1179
P407
P577
2003-07-01T00:00:00Z